Omar Ragy Patrick Hamilton Shelley Harris Sandip Mitra Kay Poulton Manchester Royal Infirmary Department of Renal Medicine Acknowledgment Introduction Idiopathic Nephrotic syndrome ID: 934433
Download Presentation The PPT/PDF document "Using Biomarkers in developing Precision..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Using Biomarkers in developing Precision Medicine in Idiopathic Nephrotic Syndrome
Omar Ragy, Patrick Hamilton, Shelley Harris, Sandip Mitra,Kay Poulton
Manchester Royal InfirmaryDepartment of Renal Medicine
Slide2Acknowledgment:
Slide3Introduction:
Idiopathic Nephrotic syndrome
MCD
FSGS
Slide4Introduction:
Idiopathic Nephrotic syndrome
MCD
FSGS
Slide5Introduction:
Idiopathic Nephrotic syndrome
MCD
FSGS
Clinical picture of nephrotic syndrome
Slide6Introduction:
Idiopathic Nephrotic syndrome
MCD
FSGS
Respond to treatment
Frequent relapses
Resistant to treatment
Slide7Introduction:
Covid -19 vaccine Nephrotic syndrome
MCD
FSGS
Slide8Aims and methods:
Idiopathic Nephrotic syndrome
Covid -19 vaccine Nephrotic syndrome
7 patients
Control cases
7 patients
7 patients
CD80
suPAR
Cytokine panel including IL10, IL15, IL2, IL4, IL5, IL6, TNF-alfa, sCD40L, MCP1, TIMP1-4
Anti
nephrin
Antibodies
Blood and Urine samples were taken pre and post immunosuppression and will
be evaluated for :
Slide9Thank you for your attention